Richard E. Lowenthal
President and CEO at ARS Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: ARS Pharmaceuticals Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2025 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $14.49 | $724,500 |
| Dec 17, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $11.67 | $583,500 |
| Dec 17, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $11.67 | $583,500 |
| Dec 10, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $13.17 | $658,500 |
| Dec 10, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $13.16 | $658,000 |
| Dec 6, 2024 | ARS Pharmaceuticals Inc. | Option exercise | +11,876 | $8.42 | $99,996 |
| Dec 6, 2024 | ARS Pharmaceuticals Inc. | Option exercise | +13,789 | $1.44 | $19,856 |
| Dec 6, 2024 | ARS Pharmaceuticals Inc. | Option exercise | +11,876 | $8.42 | $99,996 |
| Nov 19, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $13.95 | $697,500 |
| Nov 19, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $13.95 | $697,500 |
| Nov 12, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −45,045 | $16.76 | $754,954 |
| Nov 12, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −4,955 | $17.64 | $87,406 |
| Nov 12, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −45,124 | $16.76 | $756,278 |
| Nov 12, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −4,876 | $17.64 | $86,013 |
| Oct 15, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −48,550 | $14.86 | $721,453 |
Questions about Richard E. Lowenthal
What boards is Richard E. Lowenthal on?
Richard E. Lowenthal sits on the board of ARS Pharmaceuticals Inc.
What company is Richard E. Lowenthal the CEO of?
Richard E. Lowenthal is President and CEO of ARS Pharmaceuticals Inc.
How long has Richard E. Lowenthal served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.